Global Biologics Market: Size & Forecasts with Impact Analysis of Covid-19 (2020-2024 Edition)
Scope of the Report
The report entitled “Global Biologics Market: Size & Forecasts with Impact Analysis of Covid-19 (2020-2024 Edition)”, provides an in-depth analysis of the global biologics market with detailed analysis of the market in terms of value and segments.
The report includes a brief regional analysis of North America, South America, Europe, Asia Pacific and Middle East & Africa with their actual and forecasted market size. Under competitive landscape, key competitors in the market have been compared on the basis of share.
Moreover, the report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global biologics market has also been forecasted for the years 2020-2024 , taking into consideration the previous growth patterns, the growth drivers and the current and future trends.
Abbvie Inc., Samsung Electronics (Samsung Biologics), F. Hoffmann La Roche and Amgen Inc. are some of the key players operating in the global biologics market, whose company profiling has been done in the report. In this segment of the report, business overview, financial overview and business strategies of the respective companies are provided.
Company Coverage
The global biologics market has increased over the years and projections are made that the market would grow at a steady pace in the next four years i.e. 2020-2024. The market is supported by various growth drivers such as rise in sedentary lifestyle, hike in spending on healthcare, increasing biologics approval, growing incidence of chronic conditions among the aging population, increased availability of advanced diagnostics, rising auto-immune diseases, higher usage of monoclonal antibodies for the treatment of different diseases and advancement in healthcare & biotechnology.
Yet the market faces some restraints which are obstructing the growth of the market. Some of the major challenges faced by the industry are emergence of biosimilars, high cost of biologics, lack of oral absorption and operational challenges. Ongoing Covid-19 pandemic is posing challenges for the market as far as the year 2020 is concerned.
The report entitled “Global Biologics Market: Size & Forecasts with Impact Analysis of Covid-19 (2020-2024 Edition)”, provides an in-depth analysis of the global biologics market with detailed analysis of the market in terms of value and segments.
The report includes a brief regional analysis of North America, South America, Europe, Asia Pacific and Middle East & Africa with their actual and forecasted market size. Under competitive landscape, key competitors in the market have been compared on the basis of share.
Moreover, the report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global biologics market has also been forecasted for the years 2020-2024 , taking into consideration the previous growth patterns, the growth drivers and the current and future trends.
Abbvie Inc., Samsung Electronics (Samsung Biologics), F. Hoffmann La Roche and Amgen Inc. are some of the key players operating in the global biologics market, whose company profiling has been done in the report. In this segment of the report, business overview, financial overview and business strategies of the respective companies are provided.
Company Coverage
- Abbvie Inc
- Samsung Electronics (Samsung Biologics)
- F.Hoffmann La Roche
- Amgen Inc.
- North America
- South America
- Europe
- Asia Pacific
- Middle East and Africa
The global biologics market has increased over the years and projections are made that the market would grow at a steady pace in the next four years i.e. 2020-2024. The market is supported by various growth drivers such as rise in sedentary lifestyle, hike in spending on healthcare, increasing biologics approval, growing incidence of chronic conditions among the aging population, increased availability of advanced diagnostics, rising auto-immune diseases, higher usage of monoclonal antibodies for the treatment of different diseases and advancement in healthcare & biotechnology.
Yet the market faces some restraints which are obstructing the growth of the market. Some of the major challenges faced by the industry are emergence of biosimilars, high cost of biologics, lack of oral absorption and operational challenges. Ongoing Covid-19 pandemic is posing challenges for the market as far as the year 2020 is concerned.
1.EXECUTIVE SUMMARY
2. INTRODUCTION
2.1 Pharmaceutical Industry: An Overview
2.1.1 Segmentation of Pharmaceutical Industry (Drugs)
2.2 Biologics: An Overview
2.2.1 Biologics Definition
2.2.2 Biologics Medical Use
2.2.3 Difference between Chemical Drugs and Biologics
2.2.4 Key Biologics Product US/EU Expiry Date
2.3 Biologics Manufacturing Process
2.3.1 Biologics Manufacturing Process
2.4 Biologics Product-Category
2.4.1 Biologics Product-Category
3. GLOBAL MARKET ANALYSIS
3.1 Global Pharmaceuticals Market Analysis
3.1.1 Global Pharmaceuticals Market by Value
3.1.2 Global Pharmaceuticals Market by Segments (Non Biologics and Biologics)
3.2 Global Biologics Market Analysis
3.2.1 Global Biologics Market by Value
3.2.2 Global Biologics Manufacturing Market by Value
3.2.3 Global Biologics Manufacturing Market by Segments
3.2.4 Global Bio CMO Market by Value
3.2.5 Global Biologics In-House Market by Value
3.3 Global Biologics Market Product Analysis
3.3.1 Global Biologics Market by Product-Category
3.3.2 Global Biologics Monoclonal Antibodies Market by Value
3.3.3 Global Biologics Recombinant Protein Market by Value
3.3.4 Global Biologics Vaccines Market by Value
3.3.5 Global Biologics Regenerative Medicines Market by Value
3.4 Global Biologics Market Therapeutic Area Analysis
3.4.1 Global Biologics Market by Therapeutic Areas
3.4.2 Global Inflammatory Diseases Biologics Market by Value
3.4.3 Global Oncology and Immunomodulatory Biologics Market by Value
3.4.4 Global Anti-Infectives Biologics Market by Value
3.5 Global Biologics Market Regional Analysis
3.5.1 Global Biologics Market by Region
4. REGIONAL ANALYSIS
4.1 North America Biologics Market Analysis
4.1.1 North America Biologics Market by Value
4.2 South America Biologics Market Analysis
4.2.1 South America Biologics Market by Value
4.3 Europe Biologics Market Analysis
4.3.1 Europe Biologics Market by Value
4.4 Asia Pacific Biologics Market Analysis
4.4.1 Asia Pacific Biologics Market by Value
4.5 Middle East and Africa Biologics Market Analysis
4.5.1 Middle East and Africa Biologics Market by Value
5. IMPACT OF COVID-19
5.1 Impact on Global Bio CMO Market
5.1.1 CMO Market and Covid-19
5.1.2 Participation of CDMOs in Covid-19 Vaccine Development Projects
5.1.3 CDMOs Planning for Fill and Finish Manufacture of Covid-19 Vaccine
6. MARKET DYNAMICS
6.1 Growth Drivers
6.1.1 Rise in Sedentary Lifestyle
6.1.2 Hike in Spending on Healthcare
6.1.3 Elevation in Biologics Approvals
6.1.4 Rising Autoimmune Disease Prevalence
6.1.5 Preference of Biologics Over Small Molecules
6.2 Challenges
6.2.1 Growing Number of Biosimilars
6.2.2 Lack of Oral Absorption
6.2.3 Operational and Technological Challenges
6.2.4 High Cost
6.3 Market Trends
6.3.1 Research and Development Activities (R&D) Activities
6.3.2 Spike in Mergers and Acquisitions (M&A) Activity
6.3.3 Demand of Biologics in the Treatment of Complex Diseases
6.3.4 Biologics for the Treating of Dermatological Conditions
6.3.5 Advancement in Healthcare and Biotechnology
6.3.6 Commercial Success of Biotech Products
6.3.7 Reimbursement Policy
7. COMPETITIVE LANDSCAPE
7.1 Global Biologics Market Players Analysis
7.1.1 Global Biologics Market by Top Selling Drugs
7.1.2 China Biologics Market Players by Share
8. COMPANY PROFILES
8.1 Abbvie Inc.
8.1.1 Business Overview
8.1.2 Financial Overview
8.1.3 Business Strategy
8.2 Samsung Electronics (Samsung Biologics)
8.2.1 Business Overview
8.2.2 Financial Overview
8.2.3 Business Strategy
8.3 F. Hoffmann La Roche
8.3.1 Business Overview
8.3.2 Financial Overview
8.3.3 Business Strategy
8.4 Amgen Inc.
8.4.1 Business Overview
8.4.2 Financial Overview
8.4.3 Business Strategy
2. INTRODUCTION
2.1 Pharmaceutical Industry: An Overview
2.1.1 Segmentation of Pharmaceutical Industry (Drugs)
2.2 Biologics: An Overview
2.2.1 Biologics Definition
2.2.2 Biologics Medical Use
2.2.3 Difference between Chemical Drugs and Biologics
2.2.4 Key Biologics Product US/EU Expiry Date
2.3 Biologics Manufacturing Process
2.3.1 Biologics Manufacturing Process
2.4 Biologics Product-Category
2.4.1 Biologics Product-Category
3. GLOBAL MARKET ANALYSIS
3.1 Global Pharmaceuticals Market Analysis
3.1.1 Global Pharmaceuticals Market by Value
3.1.2 Global Pharmaceuticals Market by Segments (Non Biologics and Biologics)
3.2 Global Biologics Market Analysis
3.2.1 Global Biologics Market by Value
3.2.2 Global Biologics Manufacturing Market by Value
3.2.3 Global Biologics Manufacturing Market by Segments
3.2.4 Global Bio CMO Market by Value
3.2.5 Global Biologics In-House Market by Value
3.3 Global Biologics Market Product Analysis
3.3.1 Global Biologics Market by Product-Category
3.3.2 Global Biologics Monoclonal Antibodies Market by Value
3.3.3 Global Biologics Recombinant Protein Market by Value
3.3.4 Global Biologics Vaccines Market by Value
3.3.5 Global Biologics Regenerative Medicines Market by Value
3.4 Global Biologics Market Therapeutic Area Analysis
3.4.1 Global Biologics Market by Therapeutic Areas
3.4.2 Global Inflammatory Diseases Biologics Market by Value
3.4.3 Global Oncology and Immunomodulatory Biologics Market by Value
3.4.4 Global Anti-Infectives Biologics Market by Value
3.5 Global Biologics Market Regional Analysis
3.5.1 Global Biologics Market by Region
4. REGIONAL ANALYSIS
4.1 North America Biologics Market Analysis
4.1.1 North America Biologics Market by Value
4.2 South America Biologics Market Analysis
4.2.1 South America Biologics Market by Value
4.3 Europe Biologics Market Analysis
4.3.1 Europe Biologics Market by Value
4.4 Asia Pacific Biologics Market Analysis
4.4.1 Asia Pacific Biologics Market by Value
4.5 Middle East and Africa Biologics Market Analysis
4.5.1 Middle East and Africa Biologics Market by Value
5. IMPACT OF COVID-19
5.1 Impact on Global Bio CMO Market
5.1.1 CMO Market and Covid-19
5.1.2 Participation of CDMOs in Covid-19 Vaccine Development Projects
5.1.3 CDMOs Planning for Fill and Finish Manufacture of Covid-19 Vaccine
6. MARKET DYNAMICS
6.1 Growth Drivers
6.1.1 Rise in Sedentary Lifestyle
6.1.2 Hike in Spending on Healthcare
6.1.3 Elevation in Biologics Approvals
6.1.4 Rising Autoimmune Disease Prevalence
6.1.5 Preference of Biologics Over Small Molecules
6.2 Challenges
6.2.1 Growing Number of Biosimilars
6.2.2 Lack of Oral Absorption
6.2.3 Operational and Technological Challenges
6.2.4 High Cost
6.3 Market Trends
6.3.1 Research and Development Activities (R&D) Activities
6.3.2 Spike in Mergers and Acquisitions (M&A) Activity
6.3.3 Demand of Biologics in the Treatment of Complex Diseases
6.3.4 Biologics for the Treating of Dermatological Conditions
6.3.5 Advancement in Healthcare and Biotechnology
6.3.6 Commercial Success of Biotech Products
6.3.7 Reimbursement Policy
7. COMPETITIVE LANDSCAPE
7.1 Global Biologics Market Players Analysis
7.1.1 Global Biologics Market by Top Selling Drugs
7.1.2 China Biologics Market Players by Share
8. COMPANY PROFILES
8.1 Abbvie Inc.
8.1.1 Business Overview
8.1.2 Financial Overview
8.1.3 Business Strategy
8.2 Samsung Electronics (Samsung Biologics)
8.2.1 Business Overview
8.2.2 Financial Overview
8.2.3 Business Strategy
8.3 F. Hoffmann La Roche
8.3.1 Business Overview
8.3.2 Financial Overview
8.3.3 Business Strategy
8.4 Amgen Inc.
8.4.1 Business Overview
8.4.2 Financial Overview
8.4.3 Business Strategy
LIST OF FIGURES
Figure 1: History of Pharmaceutical Industry
Figure 2: Pharmaceutical Industry Segments
Figure 3: Biologics Manufacturing Process
Figure 4: Biologics Product-Category
Figure 5: Global Pharmaceuticals Market by Value; 2015-2019 (US$ Billion)
Figure 6: Global Pharmaceuticals Market by Value; 2020-2024 (US$ Billion)
Figure 7: Global Pharmaceuticals Market by Segments; 2019 (Percentage,%)
Figure 8: Global Biologics Market by Value; 2015-2019 (US$ Billion)
Figure 9: Global Biologics Market by Value; 2020-2024 (US$ Billion)
Figure 10: Global Biologics Manufacturing Market by Value; 2015-2019 (US$ Billion)
Figure 11: Global Biologics Manufacturing Market by Value; 2020-2024 (US$ Billion)
Figure 12: Global Biologics Manufacturing Market by Segments; 2019 (Percentage,%)
Figure 13: Global Bio CMO Market by Value; 2015-2019 (US$ Billion)
Figure 14: Global Bio CMO Market by Value; 2020-2024 (US$ Billion)
Figure 15: Global Biologics In-House Market by Value; 2015-2019 (US$ Billion)
Figure 16: Global Biologics In-House Market by Value; 2020-2024 (US$ Billion)
Figure 17: Global Biologics Market by Product-Category; 2019 (Percentage,%)
Figure 18: Global Biologics Monoclonal Antibodies Market by Value; 2015-2019 (US$ Billion)
Figure 19: Global Biologics Monoclonal Antibodies Market by Value; 2020-2024 (US$ Billion)
Figure 20: Global Biologics Recombinant Protein Market by Value; 2015-2019 (US$ Billion)
Figure 21: Global Biologics Recombinant Protein Market by Value; 2020-2024 (US$ Billion)
Figure 22: Global Biologics Vaccines Market by Value; 2015-2019 (US$ Billion)
Figure 23: Global Biologics Vaccines Market by Value; 2020-2024 (US$ Billion)
Figure 24: Global Biologics Regenerative Medicine Market by Value; 2015-2019 (US$ Billion)
Figure 25: Global Biologics Regenerative Medicine Market by Value; 202--2024 (US$ Billion)
Figure 26: Global Biologics Market by Therapeutic Areas; 2019 (Percentage,%)
Figure 27: Global Inflammatory Diseases Biologics Market by Value; 2015-2019 (US$ Billion)
Figure 28: Global Inflammatory Diseases Biologics Market by Value; 2020-2024 (US$ Billion)
Figure 29: Global Oncology and Immunomodulatory Biologics Market by Value; 2015-2019 (US$ Billion)
Figure 30: Global Oncology and Immunomodulatory Biologics Market by Value; 2020-2024 (US$ Billion)
Figure 31: Global Anti-Infectives Biologics Market by Value; 2015-2019 (US$ Billion)
Figure 32: Global Biologics Anti-Infectives Market by Value; 2020-2024 (US$ Billion)
Figure 33: Global Biologics Market by Region; 2019 (Percentage,%)
Figure 34: North America Biologics Market by Value; 2016-2019 (US$ Billion)
Figure 35: North America Biologics Market by Value; 2020-2024 (US$ Billion)
Figure 36: South America Biologics Market by Value; 2016-2019 (US$ Billion)
Figure 37: South America Biologics Market by Value; 2020-2024 (US$ Billion)
Figure 38: Europe Biologics Market by Value; 2016-2019 (US$ Billion)
Figure 39: Europe Biologics Market by Value; 2020-2024 (US$ Billion)
Figure 40: Asia Pacific Biologics Market by Value; 2016-2019 (US$ Billion)
Figure 41: Asia Pacific Biologics Market by Value; 2020-2024 (US$ Billion)
Figure 42: Middle East and Africa Biologics Market by Value; 2016-2019 (US$ Billion)
Figure 43: Middle East and Africa Biologics Market by Value; 2020-2024 (US$ Billion)
Figure 44: Biologics as a Percentage of Total Drug Approvals; 2012-2018
Figure 45: Prevalence of Diagnosed Autoimmune Conditions; 2018
Figure 46: Global Biopharmaceuticals (Drugs) Market by Segments;2006-2020
Figure 47: China Biologics Market Players by Share; 2019
Figure 48: Abbvie Inc. Sales; 2015-2019 (US$ Billion)
Figure 49: Abbvie Inc. Sales by Product; 2019
Figure 50: Abbvie Inc. Sales by Geography; 2019
Figure 51: Samsung BioLogics Revenue; 2015-2019 (US$ Million)
Figure 52: Roche Holding AG Sales; 2015-2019 (US$ Billion)
Figure 53: Roche Holding AG Sales by Segments; 2019
Figure 54: Roche Holding AG Sales by Region; 2019
Figure 55: Amgen Total Revenue; 2015-2019 (US$ Billion)
Figure 56: Amgen Total Revenue by Products; 2019
Figure 57: Amgen Total Revenue by Region; 2019
Table 1: Chemical Drugs vs. Biologics
Table 2: Key Biologics Product US/EU Expiry Date
Table 3: Major Biologics Patent Expiration between 2015-2025E
Table 4: Global Biologics Market by Top Selling Drugs; 2019
Table 5: HUMIRA Principal Markets
Figure 1: History of Pharmaceutical Industry
Figure 2: Pharmaceutical Industry Segments
Figure 3: Biologics Manufacturing Process
Figure 4: Biologics Product-Category
Figure 5: Global Pharmaceuticals Market by Value; 2015-2019 (US$ Billion)
Figure 6: Global Pharmaceuticals Market by Value; 2020-2024 (US$ Billion)
Figure 7: Global Pharmaceuticals Market by Segments; 2019 (Percentage,%)
Figure 8: Global Biologics Market by Value; 2015-2019 (US$ Billion)
Figure 9: Global Biologics Market by Value; 2020-2024 (US$ Billion)
Figure 10: Global Biologics Manufacturing Market by Value; 2015-2019 (US$ Billion)
Figure 11: Global Biologics Manufacturing Market by Value; 2020-2024 (US$ Billion)
Figure 12: Global Biologics Manufacturing Market by Segments; 2019 (Percentage,%)
Figure 13: Global Bio CMO Market by Value; 2015-2019 (US$ Billion)
Figure 14: Global Bio CMO Market by Value; 2020-2024 (US$ Billion)
Figure 15: Global Biologics In-House Market by Value; 2015-2019 (US$ Billion)
Figure 16: Global Biologics In-House Market by Value; 2020-2024 (US$ Billion)
Figure 17: Global Biologics Market by Product-Category; 2019 (Percentage,%)
Figure 18: Global Biologics Monoclonal Antibodies Market by Value; 2015-2019 (US$ Billion)
Figure 19: Global Biologics Monoclonal Antibodies Market by Value; 2020-2024 (US$ Billion)
Figure 20: Global Biologics Recombinant Protein Market by Value; 2015-2019 (US$ Billion)
Figure 21: Global Biologics Recombinant Protein Market by Value; 2020-2024 (US$ Billion)
Figure 22: Global Biologics Vaccines Market by Value; 2015-2019 (US$ Billion)
Figure 23: Global Biologics Vaccines Market by Value; 2020-2024 (US$ Billion)
Figure 24: Global Biologics Regenerative Medicine Market by Value; 2015-2019 (US$ Billion)
Figure 25: Global Biologics Regenerative Medicine Market by Value; 202--2024 (US$ Billion)
Figure 26: Global Biologics Market by Therapeutic Areas; 2019 (Percentage,%)
Figure 27: Global Inflammatory Diseases Biologics Market by Value; 2015-2019 (US$ Billion)
Figure 28: Global Inflammatory Diseases Biologics Market by Value; 2020-2024 (US$ Billion)
Figure 29: Global Oncology and Immunomodulatory Biologics Market by Value; 2015-2019 (US$ Billion)
Figure 30: Global Oncology and Immunomodulatory Biologics Market by Value; 2020-2024 (US$ Billion)
Figure 31: Global Anti-Infectives Biologics Market by Value; 2015-2019 (US$ Billion)
Figure 32: Global Biologics Anti-Infectives Market by Value; 2020-2024 (US$ Billion)
Figure 33: Global Biologics Market by Region; 2019 (Percentage,%)
Figure 34: North America Biologics Market by Value; 2016-2019 (US$ Billion)
Figure 35: North America Biologics Market by Value; 2020-2024 (US$ Billion)
Figure 36: South America Biologics Market by Value; 2016-2019 (US$ Billion)
Figure 37: South America Biologics Market by Value; 2020-2024 (US$ Billion)
Figure 38: Europe Biologics Market by Value; 2016-2019 (US$ Billion)
Figure 39: Europe Biologics Market by Value; 2020-2024 (US$ Billion)
Figure 40: Asia Pacific Biologics Market by Value; 2016-2019 (US$ Billion)
Figure 41: Asia Pacific Biologics Market by Value; 2020-2024 (US$ Billion)
Figure 42: Middle East and Africa Biologics Market by Value; 2016-2019 (US$ Billion)
Figure 43: Middle East and Africa Biologics Market by Value; 2020-2024 (US$ Billion)
Figure 44: Biologics as a Percentage of Total Drug Approvals; 2012-2018
Figure 45: Prevalence of Diagnosed Autoimmune Conditions; 2018
Figure 46: Global Biopharmaceuticals (Drugs) Market by Segments;2006-2020
Figure 47: China Biologics Market Players by Share; 2019
Figure 48: Abbvie Inc. Sales; 2015-2019 (US$ Billion)
Figure 49: Abbvie Inc. Sales by Product; 2019
Figure 50: Abbvie Inc. Sales by Geography; 2019
Figure 51: Samsung BioLogics Revenue; 2015-2019 (US$ Million)
Figure 52: Roche Holding AG Sales; 2015-2019 (US$ Billion)
Figure 53: Roche Holding AG Sales by Segments; 2019
Figure 54: Roche Holding AG Sales by Region; 2019
Figure 55: Amgen Total Revenue; 2015-2019 (US$ Billion)
Figure 56: Amgen Total Revenue by Products; 2019
Figure 57: Amgen Total Revenue by Region; 2019
Table 1: Chemical Drugs vs. Biologics
Table 2: Key Biologics Product US/EU Expiry Date
Table 3: Major Biologics Patent Expiration between 2015-2025E
Table 4: Global Biologics Market by Top Selling Drugs; 2019
Table 5: HUMIRA Principal Markets
